Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
12,116,423
-
Share change
-
+3,225,898
-
Total reported value
-
$157,285,000
-
Price per share
-
$12.99
-
Number of holders
-
55
-
Value change
-
+$36,210,346
-
Number of buys
-
45
-
Number of sells
-
14
Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q2 2021
As of 30 Jun 2021,
Vincerx Pharma, Inc. - Common Stock (VINC) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,116,423 shares.
The largest 10 holders included
SAGE RHINO CAPITAL LLC, TANG CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, Affinity Asset Advisors, LLC, Holocene Advisors, LP, RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, Rubric Capital Management LP, VANGUARD GROUP INC, and ACUTA CAPITAL PARTNERS, LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.